Phibro Animal Health Corp (NASDAQ:PAHC) Receives $37.67 Consensus PT from Analysts

Phibro Animal Health Corp (NASDAQ:PAHC) has been given an average recommendation of “Hold” by the seven brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $37.67.

Several analysts have recently issued reports on the company. Guggenheim assumed coverage on Phibro Animal Health in a research note on Thursday, May 23rd. They issued a “neutral” rating on the stock. Gabelli upgraded Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price objective on the stock in a research note on Wednesday, May 8th. They noted that the move was a valuation call. BidaskClub upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, April 29th. Finally, Barclays assumed coverage on Phibro Animal Health in a research note on Tuesday, June 11th. They issued an “underweight” rating and a $25.00 price objective on the stock.

PAHC opened at $30.86 on Wednesday. Phibro Animal Health has a 52 week low of $27.32 and a 52 week high of $54.62. The stock’s fifty day moving average price is $30.52. The stock has a market capitalization of $1.26 billion, a price-to-earnings ratio of 17.74, a P/E/G ratio of 4.37 and a beta of 0.69. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.98 and a current ratio of 3.41.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, May 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). The firm had revenue of $205.70 million for the quarter, compared to analysts’ expectations of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The company’s quarterly revenue was down 1.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 earnings per share. Research analysts expect that Phibro Animal Health will post 1.52 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend is Tuesday, September 3rd. Phibro Animal Health’s payout ratio is currently 27.59%.

A number of institutional investors have recently bought and sold shares of the business. Advisory Services Network LLC raised its stake in Phibro Animal Health by 20.4% in the fourth quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock valued at $71,000 after buying an additional 372 shares in the last quarter. FNY Investment Advisers LLC grew its holdings in shares of Phibro Animal Health by 73.3% during the second quarter. FNY Investment Advisers LLC now owns 1,040 shares of the company’s stock worth $33,000 after purchasing an additional 440 shares during the last quarter. Quantamental Technologies LLC grew its holdings in shares of Phibro Animal Health by 26.0% during the first quarter. Quantamental Technologies LLC now owns 2,358 shares of the company’s stock worth $78,000 after purchasing an additional 487 shares during the last quarter. Aperio Group LLC grew its holdings in shares of Phibro Animal Health by 3.5% during the second quarter. Aperio Group LLC now owns 14,585 shares of the company’s stock worth $463,000 after purchasing an additional 500 shares during the last quarter. Finally, Texas Permanent School Fund grew its holdings in shares of Phibro Animal Health by 4.1% during the first quarter. Texas Permanent School Fund now owns 13,773 shares of the company’s stock worth $455,000 after purchasing an additional 548 shares during the last quarter. Institutional investors own 50.21% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Further Reading: What is a balanced fund?

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.